Lactose India Ltd. logo

Lactose India Ltd. (LACTOSE)

Market Closed
11 Aug, 22:00
MSE MSE
102. 20
-1.05
-1.0169%
1.07B Market Cap
- P/E Ratio
- Div Yield
211 Volume
0 Eps
103.25
Previous Close
Add Transaction
Day Range
99.9 102.45
Year Range
76.01 136.7
Want to track LACTOSE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LACTOSE closed today lower at ₹102.2, a decrease of -1.0169% from yesterday's close, completing a monthly decrease of -3.5394% or -₹3.75. Over the past 12 months, LACTOSE stock lost -1.5414%.
LACTOSE is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1367%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

LACTOSE Chart

People also search for

Organic Recycling Systems Ltd.
240.05
-3.1861%
Mk Exim (India) Ltd.
57.53
-4.1167%
Bright Brothers Ltd.
265
+9.0535%
Basant Agro Tech (India) Ltd.
11.57
-2.0322%
Sampre Nutritions Ltd.
5.81
+3.9356%

Lactose India Ltd. (LACTOSE) FAQ

What is the stock price today?

The current price is ₹102.20.

On which exchange is it traded?

Lactose India Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is LACTOSE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.07B.

Has Lactose India Ltd. ever had a stock split?

No, there has never been a stock split.

Lactose India Ltd. Profile

Food Products Industry
Consumer Staples Sector
- CEO
MSE Exchange
INE058I01013 ISIN
India Country
140 Employees
- Last Dividend
- Last Split
- IPO Date
Lactose India Ltd. operates as a pharmaceutical company specializing in the production of excipients and active pharmaceutical ingredients (APIs) with a particular focus on lactose derivatives. Primarily serving the pharmaceutical sector, the company’s core products facilitate drug formulation processes, enhancing the efficacy and stability of medications. Lactose India Ltd.’s offerings are crucial for the pharmaceutical manufacturing industry, playing a vital role in the development of tablets and capsules by acting as fillers, binders, and carriers. Based in India, the company taps into the growing pharmaceutical sector, both domestically and internationally, by supplying to major pharmaceutical and nutraceutical markets. As the global demand for healthcare solutions expands, Lactose India Ltd. positions itself as a significant contributor to the supply chain, aiding in the creation of cost-effective and high-quality pharmaceutical products. The company’s emphasis on quality assurance and adherence to regulatory standards underscores its importance within the pharmaceutical community, enabling manufacturers to produce safe and effective medications. This positions Lactose India Ltd. as a pivotal player in the global health landscape.

Contact Information

Address: Unit No. G-02, ‘A’ Wing
Phone: 91 22 3513 1864